Journal of Clinical Chemistry and Laboratory Medicine
Open Access

Department of Clinical Chemistry, Ethiopian Public Health Institute, Addis Ababa, Ethiopia

Biography

Dr. Getachew Seid is currently working as research associate in department of tuberculosis, Ethiopian Public Health Institute, Ethiopia. His research includes: the Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia, Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia.

Publications

• Short Communication   
  Delivery of Anti-Cancer Agents as Nano-Vehicles
  Author(s): Getachew Seid*
  
  Successful malignant growth treatment stays a critical test in human medical services. Although a wide range of sorts of malignant growth treatment have been tried, researchers have now reasoned that blends of medications, or medications in addition to quality treatment, can focus on different pathways to battle disease. Nanovehicles can build drug take-up inside tumor cells; further develop bio-distribution and collection at tumor destinations. Current innovations, for instance radionuclide-drug store and nanotechnology (NT), have been applied to the improvement of numerous types of disease treatment. Ongoing examinations have demonstrated the viability of NT in disease treatment by planning a wide assortment of nanovehicles (NV) Additionally, NVs can have high medication stacking limit, exploit the upgraded penetrability and maintenance impact, which is applicable to uninvolved and .. View More»
  DOI: 10.35248/jcclm.21.4.178

  Abstract HTML PDF